Brief: Viva Biotech Sees HY Profit Up 47%
14/08/2019 14:59
Aug 14 (Reuters) - VIVA Biotech Holdings 1873.HK :
* EXPECTED TO RECORD AN INCREASE OF APPROXIMATELY 84% IN ITS
REVENUE FOR SIX MONTHS ENDED JUNE 30, 2019
* EXPECTED TO RECORD AN INCREASE OF ABOUT 47% IN NET PROFIT
EXCLUDING EXTRAORDINARY PROFIT OR LOSS FOR HY
Source text for Eikon: ID:nHKS2860h1
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical